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Abstract Little is known about factors related to patient sat-
isfaction with treatment for trigger digits. This study tested the
null hypothesis that there are no factors associated with treat-
ment satisfaction 2 months after completion of treatment (ab-
sence of triggering) or 4 months after the last visit for patients
with a trigger thumb or finger. Secondary null hypotheses
were: 1) There are no factors associated with a change in
patients' preferred treatment before and after consultation with
a hand surgeon; and 2) Initial treatment provided is not differ-
ent from final received treatment. In an observational study, 63
English-speaking adult patients were enrolled after being di-
agnosed with one or more new idiopathic trigger digits by one
of two hand surgeons, but before the hand surgeon discussed
treatment options. Patients were asked to fill out question-
naires at enrollment. Final evaluation was by phone.
Satisfaction with treatment was not related to the initial treat-
ment or other patient or disease factors. Twenty-three patients
(37 %) had a different preference for treatment after talking
with a hand surgeon. Involvement of the long and ring fingers
were the only factors associated with staying with pre-visit
treatment preferences. There was a significant difference in
proportions of the various treatments provided at enrollment
and final treatment recorded at the final phone evaluation, 14
patients (22 %) had a subsequent alternative form of treat-
ment. Patients' preferences for trigger finger treatment often
change after consulting with a hand surgeon and during treat-
ment, but these choices do not affect treatment satisfaction.
Keywords Corticosteroid injection . Open release .
Preference . Satisfaction . Treatment change . Trigger digit
Introduction
Idiopathic trigger finger and thumb are treated with splint
immobilization, corticosteroid injection, or A1-pulley release.
Because the natural history of idiopathic trigger finger is un-
known, there is no evidence that immobilization is palliative
or disease modifying. Relatively small, uncontrolled case se-
ries suggest that about half of patients are satisfied with their
symptoms after a period of splint immobilization [8, 10, 34].
Resolution of triggering after one or two corticosteroid injec-
tions varies substantially between studies (35 % and 87 % for
one and 72 % to 92 % for two injections) [1, 5, 12, 19, 21, 28,
30, 31, 41], and seems to depend on practice style (e.g., sched-
uled vs. as needed return visit; timing between injection and
return visit) and the injected steroid [29]. In general, it seems
that patients should be advised that about half of all patients
experience resolution of triggering with cortisone injections
alone [29, 39, 44]. Open surgical release has a high success
rate with few adverse events [22, 26, 42, 43]. Percutaneous
release has a success rate of 94 % according to a recent sys-
tematic review of 2114 procedures [45].
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Many patients with an idiopathic trigger digit prefer to
avoid surgery and consider it a last resort. Others find the more
immediate and near certain relief of triggering with surgery
appealing, but they may be shy about appearing to rush to
surgery. After describing the options and the best available
evidence, we help patients determine their preferences based
on their values and—if we agree—implement their treatment
decision. It is possible that an earlier decision for surgery
might be more satisfying, because of the more immediate
and definitive relief. We therefore studied factors associated
with satisfaction in the treatment of idiopathic trigger digit,
including initial treatment choice.
This study tested the null hypothesis that there are no fac-
tors associated with treatment satisfaction 2 months after com-
pletion of treatment (absence of triggering at examination) or
4 months after the last visit for patients with a trigger thumb or
finger. Secondary null hypothesis tested that there are no fac-
tors associated with a change in patients' preferred treatment
before and after consultation. Finally, we hypothesized that
initial treatment provided is not significantly different from
the final received treatment.
Materials and Methods
Under a protocol approved by our institutional review board,
75 consecutive patients diagnosed with one or more new idi-
opathic trigger digits by one of two hand surgeons were asked
to participate in this observational study. Between August
2011 and April 2014, adult, English-speaking patients with a
new idiopathic trigger digit grade 2 or 3 according to the
Quinnell grading system [37] were enrolled before one of
two hand surgeons discussed treatment options. Study enroll-
ment took fairly long since multiple clinical studies at our
service enrolled patients with a trigger digit. Exclusion criteria
were [1] patients who previously consulted a hand surgeon of
our service for any trigger digit; [2] prior treatment of the same
trigger digit(s) with a splint, corticosteroid injection or sur-
gery; [3] patients with concomitant carpal tunnel syndrome
who discussed treatment for this condition at enrollment;
and [4] pregnant women (institutional review board
mandated).
Before the surgeon discussed the treatment options and
after informed consent, subjects were asked to fill out ques-
tionnaires obtaining: demographic information; treatment
preference prior to consultation (multiple choice: cortisone
injection, surgery or “other”); pain intensity with use of an
ordinal measure from 0 (no pain) to 10 (worst possible pain)
[11]; the short version of the Disabilities of the Arm, Shoulder
and Hand (QuickDASH) [3, 17] questionnaire to evaluate up-
per extremity-specific disability; the 9-item Patient Health
Questionnaire (PHQ-9) [20] to measure depressive symp-
toms; and the Pain Self-efficacy Questionnaire (PSEQ) [32]
measuring pain self-efficacy. After discussion of treatment
options with the surgeon, the patient’s treatment choice was
recorded.
The final evaluation time was either 1 to 3 months
(2 months on average) after absence of triggering at examina-
tion or discharge from care, or between 3 and 5 months
(4 months on average) after the last visit if there was still
triggering at the last evaluation. The final evaluation was by
phone with a maximum of three attempts (institutional review
board mandated). At final evaluation, the following was re-
corded: all treatments received and the final treatment; satis-
faction with overall treatment using an ordinal scale from 0
(complete dissatisfaction) to 10 (complete satisfaction); treat-
ment helpful for relief of locking or triggering measured on an
ordinal scale from 0 (no help at all) to 10 (helped completely);
treatment helpful for pain relief measured on an ordinal scale
from 0 (no help at all) to 10 (helped completely); pain intensity
on an 11-point ordinal scale [11]; and upper extremity-specific
disability with use of the QuickDASH [3, 17].
Treatment
Patients were offered the following treatment options: 1) cor-
tisone injection, 2) open release, or 3) supportive (“other”)
treatment.
For injection a total volume of 1.0 to 1.5 mL of a 1:1
mixture of lidocaine (Hospira, Inc., Lake Forest, IL, USA)
and triamcinolone (10 mg/mL, Bristol-Myers Squibb, New
York, NY, USA by surgeon 1; 40 mg/mL, Bristol-Myers
Squibb, New York, NY, USA by surgeon 2) was used in and
around the flexor sheath at the A1-pulley with use of a 25- or
27-gauge needle as the surgeon preferred.
Patients that declined surgery or injection used either no
treatment or supportive treatments (other treatments) such as
acetaminophen or non-steroidal anti-inflammatory drugs
(NSAIDs), ice or heat, or splints. Patients who requested a
splint were advised to wear the splint at night during sleep
for 6 to 8 weeks. The splint was a custom-made hand-based
splint with the metacarpophalangeal (MCP) joint in neutral
and the interphalangeal joints free for a trigger finger, or a
custom-made thumb spica splint immobilizing the interpha-
langeal joint with the MCP joint in neutral.
Statistical Analysis
An a-priori power analysis indicated that 62 subjects would
provide 80% statistical power (β = 0.20) at an alpha of 0.05 to
detect an R-squared of 20 % for a model with 6 predictors
using linear regression analysis. To account for potential loss
of 20 % of subjects we enrolled 75 patients.
Questionnaire scores were scaled based on the completed
number of questions by the patient in case of missing items on
a questionnaire. This method was used for the PSEQ (1
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missing item in 1 patient) and PHQ-9 (1 missing item in 1
patient). We used regression prediction plus error imputation
for: 1 missing pain intensity scale, duration of symptoms for 4
patients, and 2 missing relief of pain scales.
Pain intensity, upper extremity-specific disability, pain re-
lief, relief of locking or triggering, treatment satisfaction,
change in preferred treatment before and after consultation,
and final treatment were all considered response variables
and expected to be related. These were not used as explanatory
variables.
The following variables were extremely skewed and were
therefore recoded into three categories based on the scale
score: treatment satisfaction (0–5, 6–9, and 10); treatment
helpful for pain relief (0–5, 6–9, and 10); treatment helpful
for relief of locking or triggering (0–5, 6–9, and 10); and pain
intensity at follow-up (0, 1–4, 5–10).
The Pearson Chi-Square test determined the difference be-
tween two categorical variables, unless the expected cell fre-
quency was less than five, in which case Fisher exact test was
used. A Student t-test or one-way ANOVA (analysis of vari-
ance) was used to assess differences inmean indices across the
levels of dichotomous and categorical variables, respectively.
We abstained from multivariable regression analysis for
treatment satisfaction since this variable was extremely
skewed.
A backward stepwise binary logistic regression analysis
determined predictors of a change in preferred treatment be-
fore and after consultation. Variables were entered in the re-
gression analysis if they met the criterion of P < 0.10 in bi-
variate analysis. Categorical variables with more than two
categories were transformed into dummy-coded variables be-
fore being entered into the multivariable analysis.
The Bapkar test was used to determine if there was a dif-
ference in proportions of the three different treatment options
(injection, surgery or supportive treatment) between enroll-
ment and final evaluation.
Baseline characteristics are presented as frequencies and
percentages for categorical variables, and as mean ± standard
deviation and range for continuous variables.
Participants
We enrolled a total of 75 patients, 3 patients were excluded
after initial enrollment (2 with Quinnell grade 1 and 1 with
incidental carpal tunnel syndrome), 7 patients did not answer
or return our calls, and 2 patients that were still planning open
trigger digit release more than 1 year after initial consultation
and therefore could not have a final evaluation. A cohort of 63
patients (84 %), 40 women (63 %) and 23 men (37 %) com-
pleted the study 4.8 ± 2.2 months (range, 1.6 to 13 months) on
average after enrollment. These 63 patients had 79 affected
digits (52 patients had 1 affected digit, 8 patients had 2 affect-
ed digits, 1 patient had 3 affected digits, and 2 patients had 4
affected digits). Twenty-five ring fingers (32 %), 23 thumbs
(29 %), 15 long fingers (19 %), 10 small fingers (13 %), and 6
index fingers (7.6 %) were affected.
The 63 patients that completed the study had, on average,
greater upper extremity-specific disability at enrollment than
the 9 patients that did not complete the study (P = 0.0060)
(Table 1).
Results
Predictors of Treatment Satisfaction
In bivariate analysis, initial treatment choice and the other
explanatory variables were not associated with treatment sat-
isfaction. (Table 2) Among the response variables greater re-
lief of triggering and lowerQuickDASH at the final evaluation
were associated with greater treatment satisfaction (P < 0.001
and P = 0.032, respectively), but pain intensity and relief of
pain were not.
Predictors of a Change in Preferred Treatment Before
and After Consultation
Among the 63 patients that completed the study, 39 patients
(63 %) chose to continue with their original preference after
consulting with a hand surgeon and 23 patients (37 %) chose a
different treatment than their original preference (of 29 pa-
tients who preferred an injection, 3 chose surgery, 2 a night
splint and 3 decided to wait and see; of 10 patients who pre-
ferred surgery, 2 chose an injection and 1 decided to wait and
see; and of 23 patients who preferred supportive treatment, 11
chose an injection and 1 surgery).
In bivariate analysis, involvement of the ring finger was
less common among patients that changed their preferred
treatment after consultation compared to the group that did
not (P = 0.028). (Table 3) Themultivariable logistic regression
model for no change in preferred treatment before and after
consultation included the affected long finger (odds ratio
[OR] = 9.4, P = 0.016), and affected ring finger (OR = 5.4,
P = 0.0081). (Table 4) This model explained 23 % of the
probability of no change in preferred treatment before and
after consultation.
Proportional Difference Between Initial and Final
Treatment
There was a significant difference in proportions of the vari-
ous treatments provided at enrollment and final treatment re-
corded at the final evaluation by phone (P < 0.001). After
enrollment, 35 patients had a cortisone injection, 11 patients
had a trigger finger or thumb release, 10 patients decided to
wait and see, 6 patients received splints, and 1 patient had a
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Table 1 Completers vs. non-completers
Completers vs. Non-completers n = 72
Completers Non-completers
n = 63 n = 9
Parameter Number % Number % P value
Sex 0.30
Male 23 82 5 18
Female 40 91 4 9.1
Race (n = 70) 0.90
White 58 89 7 11
Black/African American 2 100 0 0
Asian 2 100 0 0
More than 1 race 1 100 0 0
Marital status 0.87
Single 10 91 1 9.1
Married 39 89 5 11
Seperated/divorced 8 80 2 20
Widowed 8 89 1 11
Work status 0.24
Working, full-time 24 89 3 11
Working, part-time 13 100 0 0
Homemaker 2 67 1 33
Retired 20 87 3 13
Unemployed 3 60 2 40
On worker’s compensation 1 100 0 0
Physician 0.99
Surgeon 1 46 87 7 13
Surgeon 2 17 89 2 11
Trigger finger 0.36
Thumb 22 92 2 8.3
Index finger 1 50 1 50
Long finger 7 78 2 22
Ring finger 17 85 3 15
Small finger 5 83 1 17
More than 1 digit 11 100 0 0
Affected side 0.11
Left 21 95 1 4.5
Right 33 80 8 20
Bilateral 9 100 0 0
Dominant hand affected 0.99
No 19 86 3 14
Yes 44 88 6 12
Preferred treatment before discussion of treatment options (n = 71) 0.24
Injection 29 94 2 6.5
Surgery 10 91 1 9.1
Other 23 79 6 21
Initial treatment 0.29
Injection 35 90 4 10
Surgery 11 73 4 27
286 J Hand Microsurg (July–December 2015) 7(2):283–293
cortisone injection for one thumb and a night splint for
the other thumb. Fourteen patients (22 %) had a subse-
quent alternative form of treatment: 3 of 10 (30 %)
patients that initially chose to wait and see and 4 of 6
patients (67 %) that initially used a splint later chose an
injection; 6 of 35 patients (17 %) who initially had a
cortisone injection later underwent surgery an average
of 6 months after injection (range, 1.5 to 11 months);
and the patient that initially chose a cortisone injection
for one thumb and a night splint for the other thumb
eventually also had a cortisone injection for the other
thumb). Two patients had a second cortisone injection
(one 5 and one 6 months after the initial injection) and
8 other patients (including 1 patient who initially chose
to wait and see and 2 that initially used a splint but
later had their first injection as a subsequent alternative
form of treatment) had a second cortisone injection after
the final phone follow-up an average of 10 months after
the first injection (range, 5–18 months).
Discussion
Injections work about half the time [29, 39, 44], but the
majority of surgeons offer cortisone injection or
splinting first, and surgery if injection is unsuccessful
[1, 7, 16, 18, 21, 25, 30, 36, 41, 44]. Many patients
that have gone through this process with one finger and
eventually had surgery choose to go directly to surgery
if another finger starts triggering. Given that little is
known about treatment satisfaction for trigger digits [5,
6, 14, 40], we addressed whether initial treatment choice
affects satisfaction. We thought that patients that had
surgery—definitive treatment—right away, might be
more satisfied.
The sample size might not detect small differences in
patient satisfaction between patients choosing injection,
surgery, or neither, and the study was powered on a
multivariable, not bivariate, analysis of treatment satis-
faction. Night splints were only offered to patients with
mild triggering (Quinnell 2 in this study) according to
our practice style. The relatively short evaluation time
affected the study: 2 patients did not complete their
follow-up because they were still planning open trigger
digit release more than 1 year after their initial consul-
tation. It is important to note that we studied symptoms
of triggering and not objective examination for trigger-
ing. Some patients learn to avoid triggering and falsely
believe they are cured. Lastly, treatment satisfaction, re-
lief of triggering, relief of pain, and pain intensity at
final evaluation were extremely skewed (high ceiling
effect) which limited statistical power, and necessitated
categorizing these measures.
The null hypothesis was confirmed: there were no
explanatory variables associated with treatment satisfac-
tion. Treatment satisfaction relates to relief of triggering
and disability, but not to relief of pain. This is consis-
tent with a retrospective questionnaire study that found
most patients valued permanent relief of triggering
symptoms [5]. Most patients had little to no pain and
low disability scores at final evaluation. Patients that
preferred to proceed directly to surgery and those that
Table 1 (continued)
Completers vs. Non-completers n = 72
Completers Non-completers
n = 63 n = 9
Other 16 94 1 5.9
More than 1 treatment 1 100 0 0
Parameter Mean (SD) Range Mean (SD) Range P value
Age (years) 63 [11] 37–90 60 [13] 39–83 0.36
Education (years) 15 (2.9) 9–22 15 (3.3) 8–19 0.82
Duration of symptoms (months) (n = 71) 3.7 (4.3) 0.5–20 6.7 (7.2) 1.25–24 0.091
Pain scale 4.6 (2.5) 0–10 4.0 (2.2) 1–7 0.51
QuickDASH score 31 [18] 0–70 19 (9.4) 4.5–41 0.0060
PSEQ score 49 [12] 12–60 54 (6.0) 42–60 0.064
PHQ-9 score 2.8 (4.9) 0–25 2.6 (2.8) 0–7 0.87
N = Number; SD = Standard Deviation; QuickDASH = Short version of Disabilities of the Arm, Shoulder and Hand questionnaire; PSEQ = Pain Self-
Efficacy Questionnaire; PHQ-9 = 9-item Patient Health Questionnaire
The numbers in bold indicate significant P values (P < 0.05)
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Table 2 Bivariate analysis - treatment satisfaction
Treatment satisfaction score n = 63
0–5 6–9 10
n = 5 n = 19 n = 39
Parameter Number % Number % Number % P value
At baseline
Sex 0.19
Male 1 4.3 10 43 12 52
Female 4 10 9 23 27 68
Race (n = 70) 0.95
White 5 8.6 17 29 36 62
Black/African American 0 0 1 50 1 50
Asian 0 0 1 50 1 50
More than 1 race 0 0 0 0 1 100
Marital status 0.90
Single 0 0 4 40 6 60
Married 4 10 11 28 24 62
Seperated/divorced 1 13 2 25 5 63
Widowed 0 0 2 33 4 67
Work status 0.95
Working, full-time 3 13 7 29 14 58
Working, part-time 1 8 4 31 8 62
Homemaker 0 0 1 50 1 50
Retired 1 5.0 7 35 12 60
Unemployed 0 0 0 0 3 100
On worker’s compensation 0 0 0 0 1 100
Physician 0.69
Surgeon 1 4 8.7 15 33 27 59
Surgeon 2 1 5.9 4 24 12 71
Trigger finger 0.46
Thumb 2 9.1 8 36 12 55
Index finger 0 0 0 0 1 100
Long finger 0 0 4 57 3 43
Ring finger 1 5.9 2 12 14 82
Small finger 0 0 1 20 4 80
More than 1 digit 2 18 4 36 5 45
Affected side 0.96
Left 1 4.8 6 29 14 67
Right 3 9.1 10 30 20 61
Bilateral 1 11 3 33 5 56
Dominant hand affected 0.87
No 1 5.3 6 32 12 63
Yes 4 9.1 13 30 27 61
Initial treatment 0.95
Injection 2 5.7 11 31 22 63
Surgery 1 9.1 4 36 6 55
Other 2 13 4 25 10 63
More than 1 treatment 0 0 0 0 1 100
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wanted to avoid surgery or even cortisone injection had
comparable satisfaction. It is worth noting that 10 of the
11 patients (91 %) that decided on surgery as their
initial treatment were moderately to completely satisfied.
A larger study might have demonstrated a difference in
treatment satisfaction by initial treatment choice. This is
consistent with the findings of Benson and Ptaszek who
found that 28 of 30 (93 %) patients were satisfied with
immediate surgical release compared to 34 of 44 (77 %)
patients after one or a maximum of 3 corticosteroid
injections [5]. In a randomized trial comparing cortico-
steroid injection to percutaneous release, patients were
Table 2 (continued)
Treatment satisfaction score n = 63
0–5 6–9 10
n = 5 n = 19 n = 39
Response variables at follow-up
Final treatment 0.13
Injection 2 5.4 8 22 27 73
Surgery 1 5.9 8 47 8 47
Other 2 22 3 33 4 44
Change in preferred treatment before
and after consultation (n = 62)
0.19
No 0 0 6 26 17 74
Yes 4 10 13 33 22 56
Relief of triggering score <0.001
0–5 3 43 3 43 1 14
6–9 0 0 7 58 5 42
10 2 4.5 9 20 33 75
Relief of pain score 0.065
0–5 2 33 2 33 2 33
6–9 1 7.7 6 46 6 46
10 2 4.5 11 25 31 70
Pain score 0.056
0 1 2.3 11 26 31 72
1–4 3 19 7 44 6 38
5–10 1 25 1 25 2 50
Parameter Mean (SD) Range Mean (SD) Range Mean (SD) Range P value
At baseline
Age (years) 62 (4.9) 55–67 61 [14] 37–90 65 (9.3) 43–86 0.45
Education (years) 16 (3.6) 12–20 15 (2.9) 12–20 15 (2.9) 9.0–22 0.70
Duration of symptoms (months) 6.0 (7.9) 1.0–20 3.2 (2.8) 0.50–12 3.7 (4.3) 0.50–20 0.43
PSEQ score 53 (6.3) 47–60 48 [11] 29–60 49 [14] 12–60 0.68
PHQ-9 score 2.2 (4.4) 0–10 1.7 (2.1) 0–7 3.5 (5.9) 0–25 0.41
At follow-up
Follow-up time (months) 4.6 (3.3) 2.4–10 5.0 (2.2) 1.7–11 4.7 (2.0) 1.6–13 0.89
Response variables at baseline
Pain scale 5.0 (1.6) 3–7 4.6 (1.9) 2–8 4.5 (2.8) 0–10 0.93
QuickDASH score 34 [24] 9.1–63 30 [14] 9.1–55 30 [19] 0–70 0.90
Response variables at follow-up
QuickDASH score 30 [31] 0–70 11 [11] 0–43 11 [14] 0–66 0.032
N = Number; SD = Standard Deviation; QuickDASH = Short version of Disabilities of the Arm, Shoulder and Hand questionnaire; PSEQ = Pain Self-
Efficacy Questionnaire; PHQ-9 = 9-item Patient Health Questionnaire
The numbers in bold indicate significant P values (P < 0.05)
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Table 3 Bivariate analysis - change in preferred treatment before and after consultation
Change in preferred treatment before and after consultation n = 62
No change Change
n = 23 n = 39
Parameter Number % Number % P value
At baseline
Sex 0.40
Male 7 30 16 70
Female 16 41 23 59
Race 0.39
White 21 37 36 63
Black/African American 1 50 1 50
Asian 0 0 2 100
More than 1 race 1 100 0 0
Marital status 0.11
Single 1 10 9 90
Married 14 37 24 63
Seperated/divorced 4 50 4 50
Widowed 4 67 2 33
Work status 0.88
Working, full-time 7 30 16 70
Working, part-time 2 15 11 85
Homemaker 2 100 0 0
Retired 10 50 10 50
Unemployed 1 33 2 67
On worker’s compensation 1 100 0 0
Physician 0.86
Surgeon 1 17 38 28 62
Surgeon 2 6 35 11 65
Trigger finger* 0.028
Thumb 5 24 16 76 0.12
Index finger 0 0 1 100 0.99
Long finger 5 71 2 29 0.090
Ring finger 10 59 7 41 0.041
Small finger 0 0.0 5 100 0.15
More than 1 digit 3 27 8 73 0.52
Affected side 0.27
Left 5 25 15 75
Right 13 39 20 61
Bilateral 5 56 4 44
Dominant hand affected 0.33
No 5 28 13 72
Yes 18 41 26 59
Response variables at follow-up
Relief of triggering score 0.85
0–5 2 29 5 71
6–9 5 42 7 58
10 16 37 27 63
Relief of pain score 0.93
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significantly more satisfied after percutaneous release
than after 1 or 2 corticosteroid injections [6]. In another
randomized trial, patients were significantly more satis-
fied after a corticosteroid injection than after 10 phys-
iotherapy sessions consisting of wax therapy, ultrasound,
stretching, muscle exercises and massage [40]. Another
retrospective study found no difference in patient satis-
faction between patients who underwent open release
and percutaneous release (98 % vs. 97 %) at an average
of 23 months [14]. What our study adds is that patients
are equally satisfied, even if they have to change treat-
ments along the way in order to resolve the triggering.
Depression and self-efficacy did not correlate with treat-
ment satisfaction in contrast to previous studies that
found a correlation between these parameters in patients
with different upper extremity conditions [2, 4, 13, 27].
It is easier to identify factors associated with greater
symptoms and disability than it is to measure factors
that determine patient satisfaction [15]. Patient satisfac-
tion seems to be a more complex and elusive construct.
It seems that the encounter with the physician has an im-
pact on patients' treatment preference in more than one-third
of patients (37%). This is in line with a recent study byDöring
et al. [9] which showed that patients preferred to make treat-
ment decisions on their own after considering a physician’s
advice. On average, patients placed most value on the health
Table 3 (continued)
Change in preferred treatment before and after consultation n = 62
No change Change
n = 23 n = 39
0–5 2 33 4 67
6–9 5 42 7 58
10 16 36 28 64
Pain score 0.58
0 17 40 26 60
1–4 4 27 11 73
5–10 2 50 2 50
Parameter Mean (SD) Range Mean (SD) Range P value
At baseline
Age (years) 64 [11] 37–84 63 [10] 43–90 0.56
Education (years) 15 (2.9) 12–20 15 (2.9) 9–22 0.70
Duration of symptoms (months) 4.0 (4.3) 0.5–20 3.1 (3.4) 0.5–19 0.40
Pain scale 4.0 (2.9) 0–10 4.8 (2.2) 1–10 0.22
QuickDASH score 30 [18] 4.5–57 30 [18] 0–70 0.98
PSEQ score 49 [11] 29–60 49 [13] 12–60 0.96
PHQ-9 score 3.8 (5.0) 0–15 2.3 (4.9) 0–25 0.26
At follow-up
Follow-up time (months) 5.1 (2.5) 1.6–13 4.6 (1.9) 1.6–11 0.39
Response variables at follow-up
QuickDASH score 9.2 [10] 0–34 13 [17] 0–70 0.29
N = Number; SD = Standard Deviation; QuickDASH = Short version of Disabilities of the Arm, Shoulder and Hand questionnaire; PSEQ = Pain Self-
Efficacy Questionnaire; PHQ-9 = 9-item Patient Health Questionnaire
*Variable entered in the multivariable analysis
The numbers in bold indicate significant P values (P < 0.05)
Table 4 Multivariable analysis - no change in preferred treatment
before and after consultation
n = 62
Parameter P value Odds ratio 95 % CI for odds ratio
Lower Upper
Trigger finger
Long finger 0.016 9.4 1.5 58
Ring finger 0.0081 5.4 1.5 19
N = Number; CI = Confidence Interval
The numbers in bold indicate significant P values (P < 0.05)
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provider’s recommendation to arrive at one treatment op-
tion for their trigger finger; besides information on the
incidence of specific benefits and risks and information
on the various treatment options, personal preferences
were fourth on the list of items that would help patients
get to a final treatment decision [9]. Patients and sur-
geons rated a corticosteroid injection as the most desir-
able of all treatment options [9], this is comparable to
56 % of our patients’ that chose a corticosteroid injec-
tion after consultation with the hand surgeon. Our find-
ing of a digit being associated to a change in preferred
treatment is likely a spurious finding.
Other studies have also shown that some trigger fin-
gers require multiple corticosteroid injections or differ-
ent kinds of treatment if the initial treatment is nonop-
erative [1, 5, 10, 12, 19, 33, 38, 41]. Effectiveness of
different splint designs has been reported to be about
50 % when only considering complete resolution [8,
10, 34], and a single corticosteroid injection is disease
modifying in over 50 % of patients [1, 5, 12, 19, 21,
28, 30, 31, 41]. Symptoms of triggering completely re-
solved in 3 of 7 patients (43 %) that only had observa-
tional treatment. Previous studies have also reported res-
olution of triggering after expectant treatment or placebo
injection but too little is known about the rate at which
this occurs and if there are any predicting factors [21,
23, 24, 30, 35]. Keeping in mind that splint treatment
was only offered to patients that had mild triggering,
while observation was offered to every patient irrespec-
tive of the severity, and most patients (60 %) were not
examined for persistent triggering, these findings sug-
gest that it would help to know more about the natural
history of a trigger digit in order to better counsel pa-
tients about the value of various treatment options.
More than half of patients were completely satisfied
with their treatment, unrelated to the type of treatment.
Our sense is that an empathetic encounter, a dispassion-
ate explanation of the best evidence about various treat-
ments, and support for each patient’s preferences and
values creates a satisfying treatment experience. A for-
mulaic approach (e.g., 2 injections and then surgery)
may not fit each patient’s preferences. In other words,
it is not about offering what we think is the best treat-
ment, but about helping patients decide what suits them.
We plan to study the influence of empathy, decision-
aids, and shared decision-making on satisfaction with
care in future studies.
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